MétaCan
Menu
← Back to cohort

The effect of prior smoking history on the molecular profile of EGFR mutant (EGFRm) non-small cell lung cancer (NSCLC).

2018· article· en· W2892376413 on OpenAlexaff
Hadas Sorotsky, Mor Moskovitz, Jessica Weiss, Melania Pintilie, Natasha B. Leighl, Penelope Ann Bradbury, Geoffrey Liu, A Rashidi Kia, Michael Cabanero, Trevor J. Pugh, Dax Torti, Ming‐Sound Tsao, Jonathon Torchia, Frances A. Shepherd

Bibliographic record

VenueJournal of Clinical Oncology · 2018
Typearticle
Languageen
FieldMedicine
TopicLung Cancer Treatments and Mutations
Canadian institutionsUniversity of TorontoOntario Institute for Cancer ResearchUniversity Health NetworkPrincess Margaret Cancer Centre
Fundersnot available
KeywordsMedicineLung cancerInternal medicineDemographicsExonOncologyStage (stratigraphy)Smoking historyEpidermal growth factor receptorExomeExome sequencingMutationCancerGeneGeneticsBiologyDemography

Abstract

fetched live from OpenAlex

8533 Background: Although EGFRm NSCLC occurs mainly in non-smoking patients, most series report 20%-35% of cases in current or previous smokers. Broad molecular profiling of EGFRm NSCLC in smokers has not been reported. Methods: Surgically resected primary EGFR exon 19 or 21 mutated NSCLC tumors from 108 patients were molecularly profiled by whole exome sequencing using the Illumina HiSeq2000 platform. Alignment and variant discovery analysis was performed according to GATK best practices workflow; 87 sequenced to a mean coverage of 65.1x. Demographics and outcomes were compared for smokers and non-smokers (non-S), and by mutation profile. Results: Of the 63 non-smokers and 24 smokers (7 current/recent within 10 years), 71% were female, 53% were non-Asian, 64.5 years was the median age and 57.5% were EGFR exon 19. Of the 87 patients, 52% were stage I, 20.5% were stage II and 27.5% were stage III+. Smoking was associated with male sex (p = 0.0028) and non-Asian ethnicity (p = 0.0006) but not with age, stage or EGFR exon 19/21 subtype. Multiple “driver” mutations occurred in tumors of 25% smokers and 23.8% non-S. TP53/EGFR co-mutation occurred in 57.9% smokers and 46.2% non-S. Total non-synonymous mutation burden (TMB) was higher in smokers: median TMB in smokers 175.35 (84.93-388.24) compared to 155.31 (56.52-414.84) in non-S (p = 0.096). The strongest prognostic factor for OS and DFS was stage (I, II, III+) (p < 0.001 for each). In univariate analysis, there was a trend to shorter OS in smokers: HR 1.9 (CI 0.98-3.67, p = 0.05). Smoking within 10 years of NSCLC diagnosis was associated with shorter DFS HR 0.37(0.13-1.09) (p = 0.06) but not OS (p = 0.34). Neither EGFRm subtype nor TP53/EGFR co-mutation was associated with DFS or OS. High TMB was associated with shorter DFS: HR above vs below the median 1.96 (CI 1.06-3.62, p = 0.028), and OS HR 2.04 (CI 1.01-4.11, p = 0.043). TMB was still significant for DFS after adjusting for smoking status (p = 0.033), but not for OS (p = 0.1). Conclusions: EGFRm NSCLC in smokers is associated with a trend to higher non-synonymous TMB. Stage remains the strongest prognostic factor, but TMB appears to have a greater effect on survival outcomes than smoking status.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.014

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0040.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.038
GPT teacher head0.438
Teacher spread0.399 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2018
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical Oncology→Same topicLung Cancer Treatments and Mutations→French-language works237,207→